Search

The article presents abstracts on medical topics which include acute chemotherapy-related toxicity in BRCA1 and BRCA2 mutation carriers treated for breast cancer in Great Britain, neoadjuvant endocrine therapy for locally advanced breast cancer, and human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.

The article presents abstracts on medical topics which include estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer, therapeutic use of doxetaxel, cisplastin and trastuzumab for human epidermal growth factor receptor 2-positive locally advanced breast cancer.

The article discusses research being done on the use of polychemotherapy in patients diagnosed with early breast cancer. It references a study published in the 2007 issue of the "Journal of National Cancer Institute." The study included 1,991 women from Great Britain and other European countries with breast cancer. It illustrated the benefits of polychemotherapy with tamoxifen. A comment on the study is also offered.